Case number 1:23-cv-00327
Bayer Intellectual Property GmbH et al v. Apotex Inc. et al > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Feb 27, 2024 | 15 | STIPULATION of Dismissal between Plaintiffs and Defendants Apotex Inc. and Apotex Corp., by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc.. (Fahnestock, Derek) Modified on 2/27/2024 (nms). (Entered: 02/27/2024) (2) |
| Feb 27, 2024 | 16 | SO ORDERED Granting (D.I. 233 in 21-md-3017-RGA-LDH; D.I. 15 in 23-cv-327-RGA) Stipulation of Dismissal between Plaintiffs and Defendants Apotex Inc. and Apotex Corp.. Signed by Judge Richard G. Andrews on 2/27/2024. Associated Cases: 1:21-md-03017-RGA-LDH, 1:23-cv-00327-RGA(nms) (Entered: 02/27/2024) (2) |
| Feb 27, 2024 | 17 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2. (Attachments: # 1 Order)(nms) (Entered: 02/27/2024) (0) |
| Jul 21, 2023 | 14 | ANSWER to 11 Answer to Complaint, Counterclaim by Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc..(Fahnestock, Derek) (Entered: 07/21/2023) (9) |
| Jun 30, 2023 | 11 | ANSWER to 1 Complaint, and COUNTERCLAIMS against Bayer AG, Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., by Apotex Inc., Apotex Corp..(Hitch, Cortlan) Modified on 6/30/2023 (nms). (Entered: 06/30/2023) (22) |
| Jun 30, 2023 | 12 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Pharmaceutical Holdings, Inc. for Apotex Inc. filed by Apotex Inc.. (Hitch, Cortlan) (Entered: 06/30/2023) (2) |
| Jun 30, 2023 | 13 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Apotex Holdings Inc. for Apotex Corp. filed by Apotex Corp.. (Hitch, Cortlan) (Entered: 06/30/2023) (2) |
| Jun 21, 2023 | 10 | MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff - filed by Apotex Corp., Apotex Inc.. (Dorsney, Kenneth) (Entered: 06/21/2023) (4) |
| Jun 21, 2023 | N/A | SO ORDERED, re (D.I. 10 in 23-cv-327-RGA; D.I. 162 in 21-md-3017-RGA) MOTION for Pro Hac Vice Appearance of Attorney Rachel Leininger Schweers and Attorney Brian Sodikoff, filed by Apotex Inc., Apotex Corp.. Signed by Judge Richard G. Andrews on 6/21/2023. Associated Cases: 1:21-md-03017-RGA, 1:23-cv-00327-RGA(nms) (Entered: 06/21/2023) (0) |
| Jun 21, 2023 | N/A | Pro Hac Vice Attorney Brian Sodikoff and Rachel L. Schweers for Apotex Corp. and Apotex Inc. added for electronic noticing. Pursuant to Local Rule 83.5 (d)., Delaware counsel shall be the registered users of CM/ECF and shall be required to file all papers. (mpb) (Entered: 06/21/2023) (0) |
| May 23, 2023 | 8 | WAIVER OF SERVICE returned executed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer AG: For Apotex Corp. waiver sent on 5/3/2023, answer due 7/3/2023. (Fahnestock, Derek) (Entered: 05/23/2023) (1) |
| May 23, 2023 | 9 | WAIVER OF SERVICE returned executed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., Bayer AG: For Apotex Inc. waiver sent on 5/3/2023, answer due 7/3/2023. (Fahnestock, Derek) (Entered: 05/23/2023) (1) |
| Mar 29, 2023 | N/A | Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. Associated Cases: 1:23-cv-00327-UNA, 1:23-cv-00334-UNA, 1:23-cv-00335-UNA(nms) (Entered: 03/29/2023) (0) |
| Mar 24, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Apotex Corp. and Apotex Inc. (Filing fee $ 402, receipt number ADEDC-4096890.) - filed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., and Bayer AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jfm) (Entered: 03/24/2023) (Main Document) (14) |
| Mar 24, 2023 | 2 | Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (jfm) (Entered: 03/24/2023) (3) |
| Mar 24, 2023 | 3 | Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: February 9, 2023. Date of Expiration of Patent: February 17, 2034.Thirty Month Stay Deadline: 8/9/2025. (jfm) (Entered: 03/24/2023) (1) |
| Mar 24, 2023 | 4 | Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 9,539,218 B2. (jfm) (Entered: 03/24/2023) (1) |
| Mar 24, 2023 | 5 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Bayer AG for Bayer Intellectual Property GmbH filed by Bayer AG, Bayer Intellectual Property GmbH. (jfm) (Entered: 03/24/2023) (1) |
| Mar 24, 2023 | 6 | Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Johnson & Johnson for Janssen Pharmaceuticals, Inc. filed by Janssen Pharmaceuticals, Inc. (jfm) (Entered: 03/24/2023) (1) |
| Mar 24, 2023 | 7 | Summons Issued as to Apotex Corp. and Apotex Inc. on 3/24/2023. (Attachments: # 1 Summons Issued Apotex Inc.)(jfm) (Entered: 03/24/2023) (Main Document) (2) |
| Mar 24, 2023 | N/A | Remark: MDL panel has been advised (jfm) (Entered: 03/24/2023) (0) |
| Mar 24, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Apotex Corp. and Apotex Inc. (Filing fee $ 402, receipt number ADEDC-4096890.) - filed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., and Bayer AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jfm) (Entered: 03/24/2023) (Exhibit A) (14) |
| Mar 24, 2023 | 1 | COMPLAINT for PATENT INFRINGEMENT filed against Apotex Corp. and Apotex Inc. (Filing fee $ 402, receipt number ADEDC-4096890.) - filed by Bayer Intellectual Property GmbH, Janssen Pharmaceuticals, Inc., and Bayer AG. (Attachments: # 1 Exhibit A, # 2 Civil Cover Sheet)(jfm) (Entered: 03/24/2023) (Civil Cover Sheet) (2) |
| Mar 24, 2023 | 7 | Summons Issued as to Apotex Corp. and Apotex Inc. on 3/24/2023. (Attachments: # 1 Summons Issued Apotex Inc.)(jfm) (Entered: 03/24/2023) (Summons Issued Apotex Inc.) (2) |
